Email Alert | RSS    帮助

中国防痨杂志 ›› 2000, Vol. 22 ›› Issue (3): 151-153.

• 论著 • 上一篇    下一篇

2H3R3Z3S3(E3)/4H3R3方案治疗对乙肝病毒标志物阳性患者肝功能的影响

韩丹；张和武；   

  1. 武汉市结核病防治所 430030；
  • 出版日期:2000-03-10 发布日期:2000-03-10

Effect of regimen of 2H3R3Z3S3(E3)/4H3R3 on the liver function of the pulmonary tuberculosis patients with positive markers of viral hepatitis B

HAN Dan,ZHANG He-wu.   

  1. Prevetion and Treatment Institute of Tuberculosis of Wuhan 430030
  • Online:2000-03-10 Published:2000-03-10

摘要： 目的 探讨2H3R3Z3S3(E3)/4H3R3方案治疗对合并乙型肝炎病毒标习物HBsAg(+)、HBeAb(+)、HBcAb(+)肺结核患者肝功能的影响。方法 回顾性分析1994年12月至1998年12月采用2H3R3Z3S3(E3)/4H3R3方案治疗的初治涂阳并乙肝标志物HBsAg(+)、HBeAg(+)、HBcAg(+)肺结核患者肝功能的情况。以同期采用同样方案治疗的乙肝标志物五项阴性肺结核患者为对照。结果 乙肝阳性组肝损率 (15.6%)高于乙肝阴性组 (12.0%)。两组经统计学处理无显著性差异。 (P＞0.05)。结论2H3R3Z3S3(E3)/4H3R3方案治疗对合并乙肝病毒标志物HBsAg(+)、HBeAg(+)、HBcAg(+)肺结核患者肝功能损害小，值得推广。

Abstract: Objective To investigate the effect of regimen of 2H3R3Z3S3(E3)/4H3R3 on the liver function of the pulmonary tuberculosis patients accompanied with positive markers of HBsAg,HBeAb,and HBcAb.Methods From December 1994 to December 1998,the liver function of the pulmonary tuberculosis patients with positive markers of HBsAg,HBeAg,and HBcAb (group Ⅰ) who were given the treatment of regimen of 2H3R3Z3S3(E3)/4H3R3,was retrospectively analyzed.Simultaneously,the Results have been compared with those of negative markers of viral hepatitis patients (group Ⅱ).Results The incidence of liver damage in group Ⅰ was 15.6%,higher than that in the group Ⅱ (12.0%),but no significant difference was found between the two groups (P＞0.05).Conclusion The regimen of 2H3R3Z3S3(E3)/4H3R3 had a slight damage to the liver function of the pulmonary tuberculosis patients with positive marker of HBsAg,HBeAb,and HBcAb and is worthy spreading.

版权所有 © 2021 中国防痨协会　　　京ICP备11029069号-1   京公网安备11010202007215号
ip访问总数:  ip当日访问总数:  当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可